The Latest Cardiac and Vascular News
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the first quarter of fiscal year 2019, which ended August 31, 2018. “Our operating and financial accomplishments during the first quarter reflect our ongoing commitment to building […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED) today announced the pricing of its initial public offering of 3,900,000 shares of common stock at a price to the public of $17.00 per share. In addition, Ra Medical has granted the underwriters a 30-day option to purchase up to an additional […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, will host a conference call to discuss its third quarter 2018 results on Wednesday, Oct. 31, 2018 at 12 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its third quarter 2018 results prior to the call. A […]
IRVINE, Calif., Sept. 26, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE :EW ), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced at a 60th anniversary educational event that the Every Heartbeat Matters initiative has exceeded the goal to impact the global burden of heart valve disease […]
Fairway, Kan. – September 26, 2018 – Flow Forward Medical Inc. (Flow Forward), a medical device company focused on improving outcomes for hemodialysis patients through the rapid creation of high-quality vascular access sites, today announced it has raised an additional $1.2 million in Series A financing from a group of investors, […]
SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical, a privately held biotechnology company founded to transform the way vascular disease is treated, today announced the formation of its scientific advisory board with seven key appointments: Gary Ansel, M.D.; Elazar Edelman, M.D., Ph.D.; William Gray, M.D.; Larry Kraiss, M.D.; Krishna Rocha-Singh, M.D.; William Sessa, Ph.D. and Craig […]
ST. LOUIS, Mo., Sept. 25, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will present at the OTCQX Virtual Investor Conference for Domestic Companies. Management will provide an overview of the Company’s technology […]
HANGZHOU, China, CAESAREA, Israel, TAMPA, Florida — September 25, 2018— Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has signed an agreement to acquire Keystone Heart Ltd., a privately-held medical device company and makers of TriGUARD 3™. The acquisition gives Venus Medtech international rights to […]
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced that Tassos Gianakakos, Chief Executive Officer, will present at the 2018 Cantor Global Healthcare Conference on Monday, October 1, 2018, at 10:05 a.m. […]
VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, announced today that it has appointed Bernard Fermini, Ph.D.as Chief Research & Development Officer. Dr. Fermini has been a leading figure and expert in cardiac safety pharmacology for […]
